Asset
BEDORADRINE SULFATE
Revenue
No revenue reported in loaded filings.
Clinical trials (4)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01013142 | phase1 | completed | 2009-11-01 | 2010-03-01 | MediciNova | Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) |
| NCT01551316 | phase1 | completed | 2012-03-01 | 2012-05-01 | MediciNova | Safety Study to Evaluate MN-221 in Chronic Obstructive Pulmonary Disease (COPD) Patients |
| NCT00679263 | phase2 | completed | 2008-02-01 | 2008-07-01 | MediciNova | Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma |
| NCT00838591 | phase2 | completed | 2009-03-01 | 2012-03-01 | MediciNova | Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma |
FDA applications (0)
This company has no applications containing this asset.